Related Experiment Videos
Identification of the gene variations in human CD22
Y Hatta1, N Tsuchiya, M Matsushita
1Department of Human Genetics, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Immunogenetics
|March 18, 1999
Summary
Genetic variations in the CD22 gene were investigated for associations with autoimmune diseases. A specific CD22 variation showed a slightly higher frequency in systemic lupus erythematosus patients, suggesting CD22 as a potential susceptibility gene.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- CD22 is a B-cell glycoprotein involved in B-cell receptor (BCR) signaling.
- Emerging evidence suggests CD22 negatively regulates BCR signal transduction.
- This role prompted investigation into CD22's potential involvement in autoimmune diseases.
Purpose of the Study:
- To investigate genetic variations in the human CD22 gene.
- To determine if these variations are associated with rheumatic diseases, specifically SLE and RA.
Main Methods:
- Variation screening of the entire CD22 coding region.
- Genomic DNA analysis from healthy Japanese individuals, SLE patients, and RA patients.
- Statistical analysis to assess the association between CD22 variations and disease status.
Main Results:
- Seven non-synonymous and four synonymous substitutions were identified in CD22.
- Intronic variations near exon-intron junctions were also found.
- The Q152E substitution showed a marginally higher frequency in SLE patients (4.4%) compared to healthy individuals (0.5%), but this was not statistically significant after correction.
Conclusions:
- Multiple genetic variants exist within the CD22 gene.
- No significant association was found between CD22 variations and RA.
- CD22 is a potential candidate gene for susceptibility to autoimmune diseases like SLE.